Haleon PLC (HLN) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Total Cash From Operating Activities Chart for Haleon PLC
Haleon PLC (HLN) operating cash flow for FY2025 was GBP 2.3B, a 1.6% change from FY2024. Haleon PLC's operating cash flow grew from GBP 786.0M in 2019 to GBP 2.3B in 2025 (197.3% over 6 years). Operating cash flow compound annual growth rate: 5-year CAGR of 10.7%.
Total Cash From Operating Activities (British Pounds)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- £32.13B
- Implied Share Price
- £3.65
- Enterprise Value
- £40.23B
- Revenue (TTM)
- £11.15B
- EBITDA
- £2.85B
- Profit Margin
- 14.55%
- Trailing P/E
- 20.29
- Forward P/E
- 18.02
- Price/Book (MRQ)
- 1.98
- Price/Sales (TTM)
- 2.88
- EV/EBITDA
- 14.21
- EV/Revenue
- 3.58
- Dividend Yield
- 1.96%
- Book Value
- £1.84
- Free Cash Flow (FY2025)
- £2.02B
- Free Cash Flow Yield
- 6.27%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.